Skip to main content
. 2019 Oct 7;7:e7686. doi: 10.7717/peerj.7686

Table 2. The IC50 values of LH3 and MnIII complex treatment against breast cancer cell lines after 24 h treatment.

Compound/Drug Cell line IC50(µg/mL)
MnIIIcomplex MCF-7 1.44 ± 0.24
MDA-MB-231 2.28 ± 0.38
LH3 MCF-7 3.51 ± 0.14
MDA-MB-231 2.41 ± 0.29
Doxorubicin MCF-7 2.55 ± 0.27
MDA-MB-231 1.84 ± 0.4
Cisplatin MCF-7 8.94 ± 0.66
MDA-MB-231 6.79 ± 1.22
Tamoxifen MCF-7 9.05 ± 0.19
MDA-MB-231 10.48 ± 0.45

Notes.

Cisplatin, doxorubicin, and tamoxifen were used as positive controls.